Hedge Fund - Vestal Point Capital
Ascendis Pharma A/S (ASND)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $37,317,000 | 1.27% | 175,000 | $206.53 |
| 2 | 2025 - Q3 (2025-09-30) | $119,286,000 | 5.39% | 600,000 | $186.52 |
| 3 | 2025 - Q2 (2025-06-30) | $34,520,000 | 1.82% | 200,000 | $162.88 |
| 4 | 2025 - Q1 (2025-03-31) | $23,401,132 | 1.67% | 150,142 | $142.85 |
| 5 | 2024 - Q4 (2024-12-31) | $71,588,400 | 4.24% | 520,000 | $131.48 |
| 6 | 2024 - Q3 (2024-09-30) | $37,327,500 | 2.83% | 250,000 | $135.05 |
| 7 | 2024 - Q2 (2024-06-30) | $102,285,000 | 7.62% | 750,000 | $136.06 |
| 8 | 2024 - Q1 (2024-03-31) | $79,364,250 | 6.56% | 525,000 | $142.72 |
| 9 | 2023 - Q4 (2023-12-31) | $78,718,750 | 8.33% | 625,000 | $99.70 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center